No corporate parent is shown
- Scrutica id
- org-juniper-pharmaceuticals-inc
Ownership chain
The main chain follows the strongest parent claim by confidence, source authority and date. Other named parents appear alongside it.
- Juniper Pharmaceuticals, Inc. (US)
Starting organisation.
The displayed ownership chain ends at Juniper Pharmaceuticals, Inc.
Suppliers and customers
Annual dollar amounts refer to the fiscal year shown; sources include SEC filings, company disclosures and licensed supply-chain data. Figures open their source details. Disclosures more than 5 years old are marked historical. Records are grouped by counterparty, with historical records after newer or undated records within each group. A product or service, a percentage (the supplier’s share of one product line in the customer’s inputs) and a sole-source mark appear only where the record’s cited source states them for the pair; alternative suppliers may exist outside this corpus.
- ALLERGAN PLC historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → ALLERGAN PLC
FY2010 SEC EDGAR - CARDINAL HEALTH INC historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → CARDINAL HEALTH INC
FY2003 SEC EDGAR - CENCORA INC historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → CENCORA INC
FY2003 SEC EDGAR - MCKESSON CORP historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → MCKESSON CORP
FY2003 SEC EDGAR - MERCK SERONO SA historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → MERCK SERONO SA
FY2001 SEC EDGAR - WARNER-LAMBERT CO historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → WARNER-LAMBERT CO
FY1992 SEC EDGAR - WYETH historical
SEC segment disclosure: JUNIPER PHARMACEUTICALS INC → WYETH
FY1997 SEC EDGAR
Related analysis
Geographic revenue, business segments and capital allocation are unavailable from the licensed financial dataset. No stock ticker or SEC filing identifier is recorded for Juniper Pharmaceuticals, Inc. The public industry classification (SIC, NAICS) is also unrecorded. Sources and publication limits.